Rheumatology NewsFull resolution of psoriasis in half of ixekizumab patientsJune 14, 2016SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsDoctors ask Congress to stop Part B drug payment testMay 17, 2016SpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisBusiness of Medicine
Rheumatology NewsSerious infections are increasing among psoriasis inpatientsMay 16, 2016SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsPIANO study provides insight on safety of biologics in pregnancyMay 11, 2016Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsBrodalumab effective for rare, severe types of psoriasisMay 6, 2016SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsRemicade to infliximab biosimilar switches fare well in real-life practiceMay 3, 2016SpondyloarthropathiesRheumatoid ArthritisAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsEffective psoriasis therapy may reduce coronary plaque burdenApril 28, 2016Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsAfter Inflectra’s approval, challenges remain for biosimilarsApril 26, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisLupus & Connective Tissue DiseasesPediatricsSpondyloarthropathies
Rheumatology NewsPsoriasis tied to abdominal aortic aneurysm in nationwide studyApril 14, 2016SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsClazakizumab safe, effective for PsA treatmentApril 8, 2016Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsInflectra becomes first FDA-approved biosimilar for inflammatory diseasesApril 5, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Rheumatology NewsSevere psoriasis, kidney disease linkedApril 2, 2016Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsHow to beat apremilast-induced diarrheaMarch 31, 2016SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsHow to beat apremilast-induced diarrheaMarch 31, 2016SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsIxekizumab approved for plaque psoriasisMarch 22, 2016Psoriatic ArthritisSpondyloarthropathies
